Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Andrx Asks FDA To Reconsider Petition To Block Biovail Diltiazem ER Generic

Dec 06 1999

• By The Pink Sheet

Related Content

Biovail Tiazac Market Share Is Significant Enough To Be Reference Drug - FDA

Aug 17 1998

Andrx Generic Diltiazem Will Launch After Hoechst Patent Suit Settlement

Jun 14 1999

Citizen Petitions Cannot Be Used To Block Generics - FDA Proposed Rule

Dec 06 1999

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window